TAS6417 - Moligand™, 10mM in DMSO , Epidermal growth factor receptor erbB1 inhibitor, CAS No.1661854-97-2, Epidermal growth factor receptor erbB1 inhibitor

CAS: 1661854-97-2 Cat. No.: T422062 Summenformel: C23H20N6O Molekulargewicht: 396.44 PubChem CID: 117918742
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
2-Propenamide, N-((8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido(5,4-b)indolizin-8-yl)-|tert-butoxycarbonylamino-(dimethoxy-phosphoryl)-acetic acid methyl ester|CLN-081|N-[(8S)-4-Amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide|(S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide|Zipalertinib [INN]|Cln 081|TAS6417|TAS-6417|Zipalertinib|TPC064|TPC-064|1-(tert-butoxycarbonyl)piperidin-4-carboxylic acid methyl ester|CLN 081 [WHO-DD]
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1ml
T422062-1ml
—
2 Auf Lager

107,51€

126,60€
Speichern 19,09 € (15.08%)
Enter a quantity for the sizes you want to add.

Übersicht

Information

TAS6417 (CLN-081, TPC-064) is a novelEGFRinhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. IC50 values ranges from 1.1 ± 0.1 to 8.0 ± 1.1 nmol/L.

Targets

EGFR(d746-750/T790M) (Cell-free assay); TXK (Cell-free assay); EGFR(d746-750) (Cell-free assay); EGFR L858R (Cell-free assay); EGFR T790M/L858R (Cell-free assay) 31954,1.1 nM; 1.1 nM; 1.4 nM; 1.9 nM; 2 nM

In vitro

Of the 255 kinases tested, TAS6417 inhibits 25 kinases other than EGFR with IC50 values less than 1,000 nmol/L, which was 100 times higher than its IC50 value against WT EGFR. It inhibits only six kinases containing TXK, BMX, HER4, TEC, BTK, and JAK3, with IC50 values less than 10 times that against WT EGFR. TAS6417 inhibits proliferation of Ba/F3 cells driven by various EGFR exon 20 insertion mutations, with IC50 values ranging from 5.05 ± 1.33 nmol/L to 150 ± 53 nmol/L. It also suppresses the growth of cells expressing exon 20 insertion mutations of the EGFR gene, with a GI50 value of 86.5 ± 28.5 nmol/L for LXF 2478L cells and 45.4 ± 2.6 nmol/L for NCI-H1975 EGFR D770_N771insSVD cells. TAS6417 has no effect on EGFR-independent proliferation in NCI-H23 or NCI-H460 cells.

In vivo

TAS6417 causes persistent tumor regression in vivo in EGFR exon 20 insertion-driven tumor models. The tumor regression occurrs quickly after TAS6417 treatment and persists during the treatment period. Pharmacokinetic analysis reveals that the plasma concentration of TAS6417, administered at 50 and 100 mg/kg to mice, decreases rapidly in the first 4 hours. In contrast, although the effective doses in the rat model exhibit lower maximum plasma concentration (Cmax) values than those in the mouse model, the plasma concentrations tend to be more persistent, lasting up to 8 hours. TAS6417 inhibits mutant EGFR in tumors but not WT EGFR in skin tissues. It prolongs survival of animals bearing lung cancer.

Cell Research(from reference)

Cell lines:LXF 2478L cells and NCI-H1975 EGFR D770_N771insSVD cells 

Concentrations:0-1 μM 

Incubation Time:6 and 24 hours 

Spezifikationen

Synonyme
2-Propenamide, N-((8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido(5,4-b)indolizin-8-yl)- | tert-butoxycarbonylamino-(dimethoxy-phosphoryl)-acetic acid methyl ester | CLN-081 | N-[(8S)-4-Amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide | (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydrop Show more
Spezifikationen & Reinheit
Moligand™, 10mM in DMSO
Biochemische und physiologische Mechanismen
TAS6417 (CLN-081, TPC-064) is a novel EGFR inhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. IC50 values ranges from 1.1 ± 0.1 to 8.0 ± 1.1 nmol/L.
Storage
Store at -80°C
Verschickt in
Dry ice packs + Cold packs
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Epidermal growth factor receptor erbB1 inhibitor
Produkteigenschaften
ALogP
3.124
HBD-Zahl
2
Rotationsfähige Bindung
3
Namen und Kennungen
Pubchem Sid
SMILES
CC1=CC(CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C
IUPAC Name
N-[(8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
InChIKey
MKCYPWYURWOKST-INIZCTEOSA-N
InChI
1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1
Isomere SMILES
CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C
PubChem CID
117918742
Molekulargewicht
396.44

Erweiterte Daten

3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
EGFR Tclin Epidermal growth factor receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDatumArtikel
H2413028H2413028Certificate of AnalysisJun 04, 2026 T422062
Chemische und physikalische Eigenschaften
DMSO (mg/ml) Maximale Löslichkeit79
DMSO (mM) Maximale Löslichkeit199.273534456664
Wasser (mg/ml) Maximale Löslichkeit<1
Molekulargewicht396.4
XLogP32.300
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass396.17 Da
Monoisotopic Mass396.17 Da
Topological Polar Surface Area98.700 Ų
Heavy Atom Count30
Formal Charge0
Complexity710.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
Piktogramm(e)
Signal
Warning
Gefahrenhinweise

H302:Harmful if swallowed

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Sicherheitshinweise

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell.

P302+P352:IF ON SKIN: wash with plenty of water.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

Lösungsrechner
Bewertungen

Kundenbewertungen

Benötigen Sie Hilfe bei der Auswahl der Qualität?

Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.

Moligand™ Qualitätsleitfaden ansehen →

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.